Wound care

Leading the way in innovation and evidence to be showcased at EWMA 2014

By: Mölnlycke Health Care, April 1 2014Posted in: Wound care

Mölnlycke Health Care has always been creating a legacy of leading the way in wound care management, and our planned activities at the EWMA 2014 congress are aimed at continuing this tradition. This years' booth will reflect the proud history of the Mölnlycke Health Care range of innovative wound care products which help minimise pain for the patient and trauma to the wound. It will also highlight the significant milestones in the publication of key clinical evidence.

Ever since the introduction of Mepitel® in 1990 to the launch of Mepilex® Transfer Ag in 2013, Mölnlycke Health Care has been leading the way in successfully developing products that professionals ask for and patients need – products that are supported by clinical evidence.

Visitors to Mölnlycke Health Care at EWMA 2014 will get a better understanding of how dressings with the unique and patented Safetac® technology can free patients from unnecessary suffering1 during their wound healing journey as well as an understanding of how using Mepilex® Border, as an adjunct to current prevention protocols can reduce pressure ulcer incidences2. Further, they will learn how Mepitel® Film can prevent radiotherapy-induced skin reactions3 and how Mepilex® Ag can reduce the cost of burns treatment4. We at Mölnlycke Health Care are proud of the level of clinical evidence that exist in support of our products.

Once a day during EWMA 2014 there will be an in-booth demonstration of Mölnlycke Health Care's new WoundEL® electro stimulation system that supports wound care managers treating hard-to-heal chronic wounds while significantly reducing wound related pain5.

As a corporate congress sponsor Mölnlycke Health Care will host a symposium on Influencing Cost Effective Wound Care. This seminar aims to evaluate the current situation for purchasing decisions in wound care across Europe and beyond, in both the prevention and treatment of chronic wounds.

Mölnlycke Health Care is looking forward to meeting you at the EWMA 2014 congress in Madrid May 14-16.

 

References:

  1. White, R. A multinational survey of the assessment of pain when removing dressings.  Wounds UK, 2008;4(1):14-22.
  2. Santamaria., N et al A randomised controlled trial of the effectiveness of soft silicone multi-layered foam dressings in the prevention of sacral and heel pressure ulcers in trauma and critically ill patients: the border trial. Int Wound J 2013; doi: 10.1111/iwj.12101.
  3. Herst, P.M., et al. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol 2014, Jan 29 {Epub ahead of print}.
  4. Silverstein, P., et al. An open parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam. J Burn Care Res 2011;32(6):627-626.
  5. Leloup, P., et al. The analgesic effect of electrostimulation (WoundEL) in the treatment of leg ulcers. International Wound Journal 2014; doi:10/1111/iwj.12211.
Share this

More from the same category

Mextra Superabsorbent

Our new Superabsorbent Wound care dressing is here! Its design is based on a unique 4-layer construction...

Meet us at EWMA 23-25 May 2012 in Vienna

We exhibit at EWMA as Corporate A Sponsors to show how our wide range of...

Ask the Experts about about the role...

Some of the world’s leading experts will take part in an outstanding symposium...

Mölnlycke Health Care acquires innovative...

Mölnlycke Health Care announces that it has acquired a pioneering electrical...

Mölnlycke Health Care Wound care - Exhibits...

Mölnlycke Health Care will take part in World Union of Wound Healing Societies...

Molnlycke.com now offers even more knowledge...

We are proud to present “Ask the experts”, the latest feature in the Knowledge...

Join us or follow us online during WUWHS...

We look forward to meeting you at the World Union of Wound Healing Societies...

WUWHS 2012 is now open!

From today the 3rd of Sept until the 6th of Sept Mölnlycke Health Care will be delighted to meet...

Dr Evan Call on the difference between...

On the 3rd of September Mölnlycke Health Care, together with some of the...

Wendy White on the topic pain as a universal...

On the 5th of September Mölnlycke Health Care, together with some of the...

Mepilex Border Heel

  // The well established and highly successful product range of Mepilex® Border continues to grow...

Do you know about Stop Pressure Ulcer...

This annual day aims to raise awareness of the global burden of pressure...

Stop Pressure Ulcers

Did you know that Stop Pressure Ulcer Awareness Day is happening this Friday 16 November? This...

EWMA pressure ulcer symposium report:...

The EWMA delegates who attended the Mölnlycke Health Care seminar on pressure...

Mepilex Transfer Ag

The efficacy of wound contact layer dressings with antimicrobial properties in clinical wound care...

Mepilex Border Post-Op

The need for a reliable, surgically safe post-operative wound dressing for both clinical and patient...

EWMA 2013

EWMA 2013 in Copenhagen, Denmark, is set to become the best-attended wound care conference ever...

Introducing Mepilex Border Flex

The Mepilex® Border product range has just become more versatile than...

Mölnlycke Health Care welcomes you to...

Every day we will "share our care" by presenting you different views on...

Construction matters: The use of multilayer...

During this year's World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - A key element in wound...

A recently published French study has confirmed the effectiveness of Mepilex®...

EWMA symposium report: Examining how...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

International DEBRA Congress 2013

Epidermolysis bullosa (EB) is a rare, inherited skin disorder which causes...

Mölnlycke Health Care presents pain...

Mölnlycke Health Care participated in two interesting congresses in Vienna,...

Mölnlycke Health Care proud sponsor...

Mölnlycke Health Care recently had the honour of sponsoring the 2013 DEBRA...

Clinical trial shows dressings have...

Hospital acquired pressure ulcers are a major challenge for medical practitioners....

ISPeW congress 2013

It is approximately one week until the inter-annual  ISPeW meeting in Miami, US. The International...

Influencing cost effective wound care

Mölnlycke Health Care has chosen "Leading the way in innovation and evidence"...

Study showing that Mepitel Film prevents...

Radiation-induced skin reactions occur in 80-90 percent of breast cancer...

Summarizing EWMA 2014 in Madrid

As in previous years, delegates who attended the EWMA 2014 Conference in...

EPUAP conference 2014

Mölnlycke Health Care will participate as corporate sponsors at EPUAP (European Pressure Ulcer Advisory...

ISBI congress 2014

This month, Mölnlycke Health Care has been attending, hosting dedicated events and been platinum...

EWMA 2015

One of the best showcases for innovation is in the sharing of knowledge and best practices, and...

EWMA 2015 recap

The annual European Wound Management Association (EWMA) event gives Mölnlycke Health Care the opportunity...

GlucanPro 3000 and GlucanPro Cream changing...

Mölnlycke Health Care has announced that it will no longer offer GlucanPro®...

Proven prevention: Proof into practice...

Hospital acquired conditions, such as pressure ulcers, are expensive and,...

Mepilex Border Post-Op wins Health Product...

Mölnlycke Health Care is proud to announce that Mepilex® Border Post-Op has...

New pressure ulcer prevention monograph...

Hospital-acquired conditions are a strategic focus area for Mölnlycke Health...